Legal basis: People's Republic of China (PRC) Vaccine Management Law.
Eleventh in the process of vaccine research and development, production and inspection, we should establish and improve the biosafety management system, strictly control the biosafety risks, strengthen the biosafety management of pathogenic microorganisms such as strains, protect the health of operators and the public, and ensure the legal and legitimate use of pathogenic microorganisms such as strains. The history, biological characteristics and generations of strains and cell lines used in vaccine development, production and inspection should be clearly defined, and detailed files should be established to ensure that the sources are legal, clear and traceable; Where the source is unknown, it shall not be used.
Article 12 People's governments at all levels and their relevant departments, disease prevention and control institutions, vaccination units, vaccine marketing license holders and vaccine industry associations shall regularly carry out publicity, education and popularization of vaccine safety laws and regulations and vaccination knowledge through activities such as National Children's Vaccination Day. The news media should carry out public welfare publicity of vaccine safety laws and regulations and vaccination knowledge, and supervise the illegal activities of vaccines by public opinion. The publicity and reporting of vaccines should be comprehensive, scientific, objective and fair.